trimethoprim has been researched along with clavulanic acid in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (27.78) | 18.7374 |
1990's | 1 (5.56) | 18.2507 |
2000's | 7 (38.89) | 29.6817 |
2010's | 5 (27.78) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Evenhuis, J; Griffin, M; Harbottle, H; McDermott, PF; Miller, RA; Welch, TJ; White, DG; Wise, D | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Bonnet, R; Casin, I; Doublet, B; Fabre, L; Le Fleche, A; Robin, F; Weill, FX | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chapin, KC; Doern, GV | 1 |
Shurin, PA; Van Hare, GF | 1 |
Lapointe, JR; Lavallée, C | 1 |
Schmid, GP | 1 |
Karachalios, GN | 1 |
Wortman, PD | 1 |
Babić-Erceg, A; Barisić, Z; Borzić, E; Carev, M; Kaliterna, V; Zoranić, V | 1 |
Dance, D | 1 |
2 review(s) available for trimethoprim and clavulanic acid
Article | Year |
---|---|
The treatment of chancroid.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Chancroid; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Erythromycin; Haemophilus ducreyi; Humans; Penicillin Resistance; Rifampin; Sulfonamides; Trimethoprim | 1986 |
Treatment and prophylaxis of melioidosis.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Burkholderia pseudomallei; Carbapenems; Ceftazidime; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Infusions, Parenteral; Melioidosis; Sulfamethoxazole; Trimethoprim | 2014 |
2 trial(s) available for trimethoprim and clavulanic acid
Article | Year |
---|---|
The treatment of chancroid.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Chancroid; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Erythromycin; Haemophilus ducreyi; Humans; Penicillin Resistance; Rifampin; Sulfonamides; Trimethoprim | 1986 |
Randomized comparative study of amoxicillin-clavulanic acid and co-trimoxazole in the treatment of acute urinary tract infections in adults.
Topics: Acute Disease; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents, Urinary; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1985 |
15 other study(ies) available for trimethoprim and clavulanic acid
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
IncA/C plasmid-mediated florfenicol resistance in the catfish pathogen Edwardsiella ictaluri.
Topics: Animals; Anti-Bacterial Agents; Catfishes; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Edwardsiella ictaluri; Enterobacteriaceae Infections; Fish Diseases; Molecular Sequence Data; Plasmids; Thiamphenicol | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Catheters, Indwelling; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Pseudomonas; Pseudomonas Infections; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Erythromycin; Haemophilus influenzae; Humans; Infant; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
Therapy of acute otitis media caused by Branhamella catarrhalis. Preliminary report.
Topics: Amoxicillin; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Neisseriaceae; Otitis Media; Penicillin Resistance; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
Antibiotic interaction of amoxycillin and clavulanic acid against 132 beta-lactamase positive Haemophilus isolates: a comparison with some other oral agents.
Topics: Amoxicillin; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Synergism; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Treatment of a Nocardia brasiliensis mycetoma with sulfamethoxazole and trimethoprim, amikacin, and amoxicillin and clavulanate.
Topics: Adult; Amikacin; Amoxicillin; Anti-Bacterial Agents; Clavulanic Acid; Clavulanic Acids; Humans; Male; Mycetoma; Nocardia Infections; Sulfamethoxazole; Trimethoprim | 1993 |
Urinary tract infections in South Croatia: aetiology and antimicrobial resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Ceftibuten; Cephalosporins; Clavulanic Acid; Croatia; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Humans; Nitrofurantoin; Norfloxacin; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 2003 |